MedTrace Logo

European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study

NCT04735666 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2300

Last updated 2026-05-01

No results posted yet for this study

Summary

University of Schleswig-Holstein Campus Kiel is sponsoring the European TauroPace Registry. This investigator-initiated local, prospective, non-interventional, multi-center study includes patients undergoing cardiac implantable electronic placement including and not limited to placement, revision with the aim to upgrade or downgrade, generator substitution, additional lead placement, revision or extraction (procedure) with adjunct TauroPace. It is planned to include a total of at least 2300 procedures (valid for safety analysis).

Conditions

  • CIED Related Infection

Interventions

DEVICE

TauroPace™

TauroPace™ is intended to be used as a disinfecting solution during any CIED related surgery procedure or handling of any uncoated or silicon-, epoxy- or polyurethane-coated CIED (including its components, e.g., leads) made of titan or stainless steel in any adult patient requiring or carrying a CIED.

Sponsors & Collaborators

  • University of Luebeck

    collaborator OTHER

  • University of Kiel

    lead OTHER

Principal Investigators

  • Hendrik Bonnemeier, PhD · University of Kiel - Medical Faculty

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-22
Primary Completion
2030-01-30
Completion
2030-01-30

Countries

  • Austria
  • France
  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04735666 on ClinicalTrials.gov